Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer

被引:29
|
作者
Man, A
Pickles, T
Chi, KN
机构
[1] British Columbia Canc Agcy, Dept Radiat, Vancouver, BC V5Z 4E6, Canada
[2] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada
来源
JOURNAL OF UROLOGY | 2003年 / 170卷 / 03期
关键词
prostate; prostatic neoplasms; radiotherapy; risk; mongoloid race;
D O I
10.1097/01.ju.0000081423.37043.b4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We compared survival outcomes in patients of Asian descent treated with curative intent radiation therapy for prostate cancer with that in the nonAsian population in British Columbia, Canada. Materials and Methods: Since 1994, 1,872 men treated with curative intent radiotherapy for prostate cancer have been followed prospectively at our-provincial institution, where cancer care delivery is coordinated for the province of British Columbia. Patients are treated uniformly based on provincial policies and guidelines. Patients were divided into 63 Asian (3.6%) and 1,804 nonAsian (96.4%) patients by surname with Asian names checked by telephone contact. Three risk groups were defined based on pretreatment prostate specific antigen, biopsy Gleason score and clinical T staging. For the whole cohort and each risk group survival was estimated using the Kaplan-Meier method and comparisons were made between the Asian and nonAsian populations. Results: The mean age of Asian and nonAsian men was 71.5 and 71 years, respectively. Median prostate specific antigen was 11.4 and 10 ng/ml, respectively (p = 0.7). Median Gleason score was 7 for Asian patients and 6 for nonAsian patients. (p = 0.002). There were twice the percentage of Asian patients with Gleason scores 8 or greater than nonAsians (26.5% vs 13.8%, p = 0.003). More Asian patients had stage 3 or 4 disease than nonAsians (44.8% vs 34.9%, p = 0.095). A greater proportion of Asian patients were classified as being at high risk than the nonAsian population (60.3% vs 47.6%, p = 0.04). For the entire cohort, and the low, intermediate and high risk groups there were no differences in time to first failure, or cause specific or overall survival for Asian vs nonAsian men. Conclusions: A greater proportion of patients of Asian descent present with high risk prostate cancer than nonAsian patients, which could be due to intrinsic biological differences and/or differences in diagnostic patterns. Survival outcomes after radiotherapy are the same for the 2 populations.
引用
收藏
页码:901 / 904
页数:4
相关论文
共 50 条
  • [41] Re: 10-Year Outcomes After Monitoring, Surgery or Radiotherapy for Localized Prostate Cancer
    Albertsen, Peter C.
    EUROPEAN UROLOGY, 2017, 72 (03) : 470 - 470
  • [42] Re: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2017, 197 (04): : 1076 - 1077
  • [43] Adjuvant Radiotherapy after radical Prostatectomy for Prostate Cancer
    Schmidt, S.
    Zengerling, F.
    UROLOGE, 2015, 54 (07): : 1017 - 1020
  • [44] Radiotherapy in the management of prostate cancer after radical prostatectomy
    Bartkowiak, Detlef
    Bottke, Dirk
    Wiegel, Thomas
    FUTURE ONCOLOGY, 2013, 9 (05) : 669 - 679
  • [45] Secondary radiotherapy does not decrease the rate of distant progression after radical prostatectomy for localized prostate cancer
    Porter, C.
    Walz, J.
    Gallina, A.
    Jeldres, C.
    Kodama, K.
    Gibbons, R.
    Correa Jr., R.
    Benard, F.
    Saad, F.
    Montorsi, F.
    Karakiewicz, P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 86 - 86
  • [46] Re: Mortality after Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer - Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2013, 190 (04): : 1247 - 1247
  • [47] Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer
    Murthy, V
    Norman, AR
    Shahidi, M
    Parker, CC
    Horwich, A
    Huddart, RA
    Bange, A
    Dearnaley, DP
    BJU INTERNATIONAL, 2006, 97 (03) : 476 - 479
  • [48] Salvage brachytherapy for localized prostate cancer after radiotherapy failure
    Grado, GL
    Collins, JM
    Kriegshauser, JS
    Balch, CS
    Grado, MM
    Swanson, GP
    Larson, TR
    Wilkes, MM
    Navickis, RJ
    UROLOGY, 1999, 53 (01) : 2 - 10
  • [49] Urinary morbidity after radiotherapy for clinically localized prostate cancer
    Valgueblasse, Eddy
    Descazeaud, Aurelien
    PROGRES EN UROLOGIE, 2009, 19 (01): : F15 - F18
  • [50] Functional Outcomes After Localized Prostate Cancer Treatment
    Al Hussein Al Awamlh, Bashir
    Wallis, Christopher J. D.
    Penson, David F.
    Huang, Li-Ching
    Zhao, Zhiguo
    Conwill, Ralph
    Talwar, Ruchika
    Morgans, Alicia K.
    Goodman, Michael
    Hamilton, Ann S.
    Wu, Xiao-Cheng
    Paddock, Lisa E.
    Stroup, Antoinette
    O'Neil, Brock B.
    Koyama, Tatsuki
    Hoffman, Karen E.
    Barocas, Daniel A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (04): : 302 - 317